Evidence map›Paper›PMID 32025748›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Aloin protects against arsenic trioxide-induced myocardial membrane damage and release of inflammatory cytokines.

Lalit A Birari, Umesh B Mahajan, Kalpesh R Patil, Dipak D Patil, Neha A Bagul, Sateesh Belemkar, Sameer N Goyal, Shreesh Ojha, Chandragouda R Patil

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lalit A BirariDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Umesh B MahajanDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Kalpesh R PatilDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Dipak D PatilDepartment of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Neha A BagulDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Sateesh BelemkarDepartment of Pharmacology, School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Sameer N GoyalDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India.
Shreesh OjhaDepartment of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, United Arab Emirates.
Chandragouda R PatilDepartment of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India. xplore.remedies@gmail.com.
Shri Vile Parle Kelavani Mandal · INNarsee Monjee Institute of Management Studies · INUnited Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aloin exerts concentration-dependent pro-oxidant and antioxidant effects when tested in vitro. Such duality of effects has not been investigated through in vivo studies on aloin. We evaluated the effects of aloin at doses ranging between 1 and 125 mg/kg against the arsenic trioxide (As

Indexed as

Arsenic TrioxideAnimalsAnti-Inflammatory AgentsAntioxidantsCardiotoxicityCell MembraneCytokinesDisease Models, AnimalDose-Response Relationship, DrugEmodinHeart DiseasesInflammation MediatorsMaleMiceMyocytes, CardiacOxidative StressalloinAnti-Inflammatory AgentsAntioxidantsArsenic TrioxideCytokinesEmodinInflammation MediatorsAloinAs2O3Myocardial damageOxidative stressTNF-α

Identifiers

PMID32025748
OpenAlexW3004954184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.